Clinical trial
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00245934 |
|---|---|
| Title | Study Evaluating Enbrel in Patients With Rheumatoid Arthritis |
| Official title | Observational Study With Enbrel in Patients With Rheumatoid Arthritis |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Enbrel |
| Enrollment | 1,500 |
| Start date | Jun 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Oct 28, 2005 |
| Last update posted | Dec 14, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: